Related Experiment Videos
Multidrug-resistant tuberculosis--can the tide be turned?
1Centre for Infectious Diseases and International Health, Royal Free and University College Medical School, Windeyer Institute for Medical Science, London, UK. a.zumla@ucl.ac.uk
The Lancet. Infectious Diseases
|March 2, 2002
Abstract:
Despite continued control efforts, tuberculosis remains a leading cause of illness and death worldwide, with more cases today than at any previous time in history. Not only is there a global increase in the disease itself, there is a worrying rise in the number of cases resistant to the two principal antituberculosis drugs, isoniazid and rifampicin--so called multidrug resistance.